ANPAC BIO-MED SP.ADS/20 A
ANPAC BIO-MED SP.ADS/20 A
Depository Receipt · US03635R2067 · ANPC (LSSI)
Overview
No Price
n/a

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
- - - - -2,36 % -0,05 % -96,82 %

Company Profile for ANPAC BIO-MED SP.ADS/20 A Depository Receipt

AnPac Bio-Medical Science Co., Ltd., a biotechnology company, researches, develops, markets, and sells multi-cancer screening and detection tests using cancer differentiation analysis technology and device to corporations and life insurance companies in the People's Republic of China. It also offers physical checkup package services. The company was incorporated in 2010 and is headquartered in Lishui, the People's Republic of China.

Company Data

Name ANPAC BIO-MED SP.ADS/20 A
Company AnPac Bio-Medical Science Co., Ltd.
Symbol ANPC
Website https://www.anpacbio.com
Primary Exchange LSSI Lang & Schwarz
ISIN US03635R2067
Asset Class Depository Receipt
Sector Healthcare
Industry Biotechnology
CEO Dr. Chris Chang Yu
Market Capitalization 27 Mio
Country China
Currency EUR
Employees 0,1 T
Address 801 Bixing Street, 323006 Lishui
IPO Date 2020-01-30

Ticker Symbols

Name Symbol
Frankfurt 0UC0.F
NASDAQ ANPC

More Shares

Investors who ANPAC BIO-MED SP.ADS/20 A hold also have the following shares in their portfolio:
LOCKHEED MARTIN 15/23
LOCKHEED MARTIN 15/23 Bond
TOYOTA M.FIN 19/22 MTN
TOYOTA M.FIN 19/22 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025